Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Baumann Confirmed As Bayer's New CEO

This article was originally published in Scrip

Executive Summary

Bayer has confirmed that its head of strategy and portfolio management, Werner Baumann, is to be its new CEO effective May 1, 2016. Current CEO Marijn Dekkers has proposed that his contract be dissolved on April 30 following the annual stockholders meeting. His contract was originally set to run until Dec. 31, 2016. Dekkers had signaled his intention to step down as CEO this year back in 2014. Baumann has been with Bayer since 1988 in a variety of roles including chief financial officer, and was credited with playing a key role in the integration of Schering following the 2006 merger with Bayer. His name had been widely linked with the top job at Bayer since Olivier Brandicourt's departure to head up Sanofi a year ago.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC064584

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel